CBR Genomics was elected to the Top 10 Emerging Next-Generation Sequencing Company in Europe 2022.

This prize is annually awarded by Life Science Review and it pretends to distinguish vanguardist companies that act in the development of applications and services related to next-generation sequencing (NGS).

The editors highlighted CBR Genomics as a company of excellence that merges genomics with medicine and technology digital.

For more information here.